← Open Payments lookup

SARA BENNETT: Open Payments

NPI 1104364173 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,881 in 88 payments from 12 companies in 2025. Trend: 2023 $481 · 2024 $947 · 2025 $10,881

Speaker / faculty: $7,560Food & beverage: $2,300Travel & lodging: $1,021
CompanyPaymentsAmount
GENZYME CORPORATION32$7,429
Regeneron Healthcare Solutions, Inc.15$2,549
AstraZeneca Pharmaceuticals LP9$281
Ionis Pharmaceuticals, Inc.7$151
GlaxoSmithKline, LLC.12$139
Novartis Pharmaceuticals Corporation3$95
BioCryst US Sales Co., LLC3$58
CSL Behring2$55
Galderma Laboratories, L.P.2$43
Takeda Pharmaceuticals U.S.A., Inc.1$38

Products named: DUPIXENT, TEZSPIRE, DAWNZERA, NUCALA, FASENRA, ORLADEYO, Hizentra, NEMLUVIO.

Industry payments across GA — which companies pay providers there.